ElectroCore inks nVNS neuroinflammatory response research deal with MGH

ElectroCore said yesterday it inked a collaborative research deal with Massachusetts General Hospital exploring the use of ElectroCore’s non-invasive vagus nerve stimulation tech in targeted treatments for neuroinflammation. The Basking Ridge, N.J.-based company said that investigators will examine the effects the nVNS system has on neuroinflammatory mechanisms associated with conditions in the central nervous system including pain, trauma and neurodegeneration. ElectroCore said it will supply up to $1 million through a research grant over four years to support preclinical trials of the device, including work already initiated this quarter. Research includes exploring the effect of nVNS on persistent neuroinflammation and neurological outcomes after concussive traumatic brain injury and the efects of the nVNS system on microglia cells and their association with the development and progression of Alzheimer’s disease. “We are proud to partner with a renowned research institution like Massachusetts General Hospital, whose core scientific mission aligns with our belief that it is through the deep understanding of the mechanisms of potential therapies that we learn to best help patients suffering from debilitating conditions. We look forward to the outputs of our collaborative research efforts to better elucidate the effects of non-invasive vagus nerve stimulation on neuroinflammation, and its role in the treatment of conditions such as Alzheimer’s disease and...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Neurological Neuromodulation/Neurostimulation electroCore Source Type: news